Compare MIST & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | ZJYL |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.9M | 145.9M |
| IPO Year | 2019 | 2020 |
| Metric | MIST | ZJYL |
|---|---|---|
| Price | $0.78 | $1.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $5.86 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 27.5K |
| Earning Date | 11-11-2026 | 08-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $147.62 | N/A |
| Revenue Next Year | $476.43 | N/A |
| P/E Ratio | ★ N/A | $18.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.75 | $0.10 |
| 52 Week High | $3.06 | $4.50 |
| Indicator | MIST | ZJYL |
|---|---|---|
| Relative Strength Index (RSI) | 31.05 | 41.88 |
| Support Level | $0.75 | $1.94 |
| Resistance Level | $1.42 | $2.18 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 13.44 | 30.30 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.